Tower Research Capital LLC (Trc) Catalent, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Catalent, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,847 shares of CTLT stock, worth $539,490. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,847
Previous 10,154
12.87%
Holding current value
$539,490
Previous $570,000
6.14%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding CTLT
# of Institutions
513Shares Held
149MCall Options Held
575KPut Options Held
2.03M-
Vanguard Group Inc Valley Forge, PA20.2MShares$1.23 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$936 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$454 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$390 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$276 Million0.14% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $11B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...